Zoetis (ZTS) Share-based Compensation (2012 - 2026)
Zoetis' (ZTS) quarterly Share-based Compensation came in at $92.0 million in Q2 2026, down 31.85% year-over-year from $135.0 million in Q2 2025, and up 39.39% quarter-over-quarter from $66.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Share-based Compensation (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Share-based Compensation for 15 consecutive years, with $92.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 31.85% year-over-year to $92.0 million in Q2 2026; TTM through Jun 2026 was $142.0 million, a 34.86% decrease from a year earlier, with the FY2025 full-year figure at $165.0 million, up 122.97% from the prior year.
- Share-based Compensation was $92.0 million for Q2 2026 at Zoetis, up from $66.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $135.0 million in Q2 2025 and troughed at -$24.0 million in Q4 2023.
- A 5-year average of $30.8 million and a median of $19.0 million in 2022 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 640.0% in 2023, down 250.0% in 2023.
- Over 5 years, Share-based Compensation stood at $16.0 million in 2022, then tumbled by 250.0% to -$24.0 million in 2023, then surged by 179.17% to $19.0 million in 2024, then sank by 152.63% to -$10.0 million in 2025, then jumped by 1020.0% to $92.0 million in 2026.
- The last three Share-based Compensation figures came in at $92.0 million (Q2 2026), $66.0 million (Q1 2026), and -$10.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.49 Bn | 40.29 Bn | 779.09 Mn | 16.09 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 92.00 Mn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 7.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 413,000.00 |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 239,867.00 |
| 6 | Zhengye Biotechnology Holding | 75.76 Mn | 68.66 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Jun 30, 2025 | 135.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 19.00 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | -24.00 Mn |
| Sep 30, 2023 | 37.00 Mn |
| Jun 30, 2023 | 58.00 Mn |
| Mar 31, 2023 | 24.00 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 22.00 Mn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 5.00 Mn |